연구성과로 돌아가기
2021 연구자 정보 (138 / 1146)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Lee, Joo Myung (Lee, JM) |
Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Dept Internal Med,Sch Med,Div Cardiol, 81 Irwon Ro, Seoul 06351, South Korea |
J-5597-2012 Lee, Jae |
|
[JCR상위 4.8] Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | myungho@chollian.net;yasuda.satoshi.hp@ncvc.go.jp; | ||
|
Lee, Kwan Sik (Lee, KS) |
Yonsei Univ, Coll Med, Gangnam Severance Hosp, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea |
D-5883-2012 Lee, Shin-Jae |
0000-0002-3672-1198 Lee, Kwan Sik |
[JCR상위 4.8] Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study [JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY |
jenny.yang@gilead.com; umsh@korea.ac.kr; |
||
|
Lee, Seung Hun (Lee, SH) |
제1저자 |
Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jaebong Ro, Gwangju 61469, South Korea Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Dept Internal Med,Sch Med,Div Cardiol, 81 Irwon Ro, Seoul 06351, South Korea |
AAW-6430-2021 Lee, Seung |
0000-0002-2337-7826 Lee, Seung Hun |
[JCR상위 4.8] Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | myungho@chollian.net;yasuda.satoshi.hp@ncvc.go.jp; | |
|
Lee, Yu Rim (Lee, YR) |
Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea Kyungpook Natl Univ Hosp, Dept Internal Med, Korea, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea Kyungpook Natl Univ, Sch Med, Internal Med, Daegu, South Korea Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea |
ITU-1407-2023 Lee, YuRim |
|
[JCR상위 4.8] An episode of detectable serum hepatitis B virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of <2, 000 IU/ml [JCR상위 25.9] Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic [JCR상위 27.6] Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients [JCR상위 71.2] Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma [JCR상위 5.9] CIRCULAR NONCODING RNA HSACIRC₀₀₀₅₉₈₆ AS A PROGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA [JCR상위 5.9] CIRCULATING EXOSOMAL LNCRNA-ATB PROMOTES MYOPENIA IN HUMAN HEPATOCELLULAR CARCINOMA [JCR상위 25.0] Circular noncoding RNA hsacᵢᵣc₀₀₀₅₉₈₆ as a prognostic biomarker for hepatocellular carcinoma [JCR상위 46.8] Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment [JCR상위 59.7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir [JCR상위 1.3] Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19 [JCR상위 32.0] A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records [JCR상위 0.2] Federated learning for predicting clinical outcomes in patients with COVID-19 |
SCIE | 0.2 |
GASTROENTEROLOGY & HEPATOLOGY MEDICAL LABORATORY TECHNOLOGY MEDICINE, GENERAL & INTERNAL MULTIDISCIPLINARY SCIENCES GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;ENGINEERING, BIOMEDICAL;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING BIOCHEMISTRY & MOLECULAR BIOLOGY;CELL BIOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL |
beomkkim@yuhs.ac; wytak@knu.ac.kr; deblue00@naver.com; ksukorea@yuhs.ac; KeunHur@knu.ac.kr; magnolia1103@naver.com;KeunHur@knu.ac.kr; chung50@dsmc.or.kr;kbs9225@cu.ac.kr; KSUKOREA@yuhs.ac; li.quanzheng@mgh.harvard.edu; MKALRA@mgh.harvard.edu;Li.Quanzheng@mgh.harvard.edu; mflores@nvidia.com; |
||
|
Lee, Yun Bin (Lee, YB) |
Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea |
AAB-9799-2022 Lee, Yoojin |
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Leung, Daniel Hao Bin (Leung, DHB) |
Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA |
|
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
Levy, Cynthia (Levy, C) |
Univ Miami, Miami, FL USA |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Liu, Yang (Liu, Y) |
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA |
|
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
Mak, Lung Yi Loey (Mak, LYL) |
Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China |
ABB-1599-2020 Mak, Lung Yi (Loey) |
|
[JCR상위 4.8] ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | jhamilton@arrowheadpharma.com; | ||
|
Manolakopoulos, Spilios (Manolakopoulos, S) |
Natl & Kapodistrian Univ Athens, Gen Hosp Athens Hippokratio, Dept Internal Med 2, Sch Med, Athens, Greece Natl & Kapodistrian Univ Athens, Sch Med, Gen Hosp Athens Laiko, Dept Gastroenterol, Athens, Greece |
AAD-7058-2019 Manolakopoulos, Spilios |
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Mayo, Marlyn J. (Mayo, MJ) |
Univ Texas Southwestern, Dallas, TX USA |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
McDonald, Circe (McDonald, C) |
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA |
|
|
[JCR상위 4.8] Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | jenny.yang@gilead.com; | ||
|
McWherter, Charles (McWherter, C) |
CymaBay Therapeut, Newark, CA USA |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Mehta, Rajiv (Mehta, R) |
Surat Inst Med Sci SIDS, Surat, India |
|
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
Michael, Galambos (Michael, G) |
Digest Healthcare Georgia, Atlanta, GA USA |
|
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; |
페이지 이동: